Planet 13 Holdings (PLNH) Current Leases (2021 - 2026)
Planet 13 Holdings' (PLNH) quarterly Current Leases came in at $1.5 million in Q1 2026, down 23.26% year-on-year from $1.9 million in Q1 2025, and up 5.09% on a QoQ basis from $1.4 million in Q4 2025.
Planet 13 Holdings (PLNH) Current Leases (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has 6 years of Current Leases data on file, last reported at $1.5 million in Q1 2026.
- On a quarterly basis, Current Leases fell 23.26% year-over-year to $1.5 million in Q1 2026; TTM through Mar 2026 was $1.5 million, a 23.26% decrease from a year earlier, with the FY2025 full-year figure at $1.4 million, down 23.81% from the prior year.
- Current Leases for Q1 2026 stood at $1.5 million, up from $1.4 million in the prior quarter.
- Over the last five years, Current Leases for PLNH reached as high as $2.1 million in Q2 2025 and fell as low as $479161.0 in Q1 2022.
- Historically, Current Leases has averaged $1.1 million across 5 years, with a median of $779389.0 in 2024.
- Across the five-year window, Current Leases jumped 210.17% in 2024 and decreased 23.81% in 2025, its largest moves.
- Year by year, Current Leases stood at $479161.0 in 2022, then soared by 40.79% to $674594.0 in 2023, then soared by 169.58% to $1.8 million in 2024, then retreated by 23.81% to $1.4 million in 2025, then rose by 5.09% to $1.5 million in 2026.
- Per Business Quant data, the three most recent Current Leases figures were $1.5 million in Q1 2026, $1.4 million in Q4 2025, and $2.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Planet 13 Holdings | 39.35 Mn | 23.09 Mn | 9.41 Mn | 1.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.46 Mn |
| Dec 31, 2025 | 1.39 Mn |
| Sep 30, 2025 | 2.02 Mn |
| Jun 30, 2025 | 2.09 Mn |
| Mar 31, 2025 | 1.90 Mn |
| Dec 31, 2024 | 1.82 Mn |
| Sep 30, 2024 | 1.73 Mn |
| Jun 30, 2024 | 1.69 Mn |
| Mar 31, 2024 | 779,389.00 |
| Dec 31, 2023 | 674,594.00 |
| Sep 30, 2023 | 580,142.00 |
| Jun 30, 2023 | 545,043.00 |
| Mar 31, 2023 | 674,594.00 |
| Dec 31, 2022 | 479,161.00 |
| Sep 30, 2022 | 479,161.00 |
| Jun 30, 2022 | 479,161.00 |
| Mar 31, 2022 | 479,161.00 |
| Dec 31, 2021 | 423,573.00 |